Skip to content

Analysis of Drug Resistance Characteristics in Pediatric Mycoplasma pneumoniae Isolates

Analysis of Drug Resistance Characteristics in Pediatric Mycoplasma pneumoniae Isolates

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500114605
Enrollment
Unknown
Registered
2025-12-15
Start date
2025-12-15
Completion date
Unknown
Last updated
2026-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mycoplasma pneumonia

Interventions

Sponsors

Beijing Fengtai District Center for Disease Control and Prevention (Beijing Fengtai District Health Inspection Institute)
Lead Sponsor

Eligibility

Sex/Gender
All
Age
1 Years to 14 Years

Inclusion criteria

Inclusion criteria: Target Population: Outpatient children aged 1–14 years with acute respiratory tract infections in this region Inclusion Criteria: 1. Meet the diagnostic criteria for community-acquired pneumonia (fever, cough, pulmonary rales + radiological findings) 2. Duration of illness <= 7 days and no prior use of macrolide antibiotics 3. Positive Mycoplasma pneumoniae nucleic acid test

Exclusion criteria

Exclusion criteria: History of macrolide use within the past week.

Design outcomes

Primary

MeasureTime frame
Mycoplasma pneumoniae P1 type;Detection of 23S rRNA A2063G and A2064G mutations in Mycoplasma pneumoniae;In vitro drug susceptibility testing of Mycoplasma pneumoniae;Whole-genome sequencing of Mycoplasma pneumoniae.;

Countries

China

Contacts

Public ContactYin Songyue

Beijing Fengtai District Center for Disease Control and Prevention (Beijing Fengtai District Health Inspection Institute)

ysy_2008@163.com+86 186 0039 1007

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026